Your browser doesn't support javascript.
loading
Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model.
Kong, Dexiao; Liu, Xia; Li, Xiaomei; Hu, Jianting; Li, Xiaoyan; Xiao, Juan; Dai, Yibo; He, Mingming; Liu, Xiaoli; Jiang, Yang; Cui, Ruodi; Zhang, Lihong; Wang, Juandong; Li, Ai; Wang, Fang; Zhang, Yuan; Xiao, Juan; Wang, Wei; Zheng, Chengyun.
Afiliação
  • Kong D; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Liu X; Department of Hematology, Zhaoyuan Sorting-Yingcheng Hospital, Second Hospital of Shandong University, Yantai, Shandong Province, China.
  • Li X; Department of Respiratory Intervention, Qilu Children's Hospital of Shandong University, Jinan, Shandong Province, China.
  • Hu J; Cancer Center, The Second Hospital of Shandong University, Jinan, Shandong Province, China.
  • Li X; Shandong Pharmaceutical Academy, Shandong Provincial Key Laboratory of Chemical Drugs, Jinan, Shandong Province, China.
  • Xiao J; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Dai Y; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • He M; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Liu X; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Jiang Y; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Cui R; Department of Hematology, Zhaoyuan Sorting-Yingcheng Hospital, Second Hospital of Shandong University, Yantai, Shandong Province, China.
  • Zhang L; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Wang J; Department of Hematology, Zhaoyuan Sorting-Yingcheng Hospital, Second Hospital of Shandong University, Yantai, Shandong Province, China.
  • Li A; Department of Radiology, Qilu Children's Hospital of Shandong University, Jinan, Shandong Province, China.
  • Wang F; Department of Pathology, Qilu Children's Hospital of Shandong University, Jinan, Shandong Province, China.
  • Zhang Y; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Xiao J; Department of Hematology, Zhaoyuan Sorting-Yingcheng Hospital, Second Hospital of Shandong University, Yantai, Shandong Province, China.
  • Wang W; Department of hematology of the Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, Shandong Province, China.
  • Zheng C; Department of Hematology, Zhaoyuan Sorting-Yingcheng Hospital, Second Hospital of Shandong University, Yantai, Shandong Province, China.
Biosci Rep ; 39(9)2019 09 30.
Article em En | MEDLINE | ID: mdl-31484796
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Estafilocócica / Transplante de Células-Tronco Mesenquimais / Staphylococcus aureus Resistente à Meticilina / Linezolida / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Biosci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Estafilocócica / Transplante de Células-Tronco Mesenquimais / Staphylococcus aureus Resistente à Meticilina / Linezolida / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Biosci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido